Battery innovation and the next wave of orthopaedic implants

Ilika Plc

Orthopaedic procedures today restore quality of life for millions each year, but failure rates remain a pressing issue. Infection, loosening, or mechanical collapse often reveal themselves only when pain returns, by which point revision surgery is the only option. The next generation of implants is being built to change that timeline entirely. By embedding sensors capable of measuring pressure, movement, and temperature, these devices can provide surgeons with a real-time window into the health of the joint.

Yet the ability to collect and send this information rests on a problem many overlook: powering the device without compromising its structural integrity. Conventional batteries are too bulky or unreliable to integrate safely into implants. This is where miniature solid state batteries enter the conversation. Designed at millimetre scale, they can be embedded within a prosthetic without weakening it, while still delivering the performance needed to drive sensors and communications.

Ilika’s Stereax M300, for instance, has been designed to address exactly these constraints. With a rectangular footprint just a few millimetres across, it offers the compactness necessary for true miniaturisation. Despite its size, it is capable of producing the pulse currents required for both sensing and wireless transmission. Equally important is the ability to recharge quickly and wirelessly, which not only ensures the longevity of the implant but also supports patient compliance by making at-home charging feasible and convenient.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Ilika moves Goliath cells into independent commercial testing

Ilika has moved its UK-made Goliath cells into independent testing as it targets commercial opportunities in automotive, defence and e-bike markets.

Ilika takes solid-state battery message to major UK energy storage conference

Ilika will present its UK-developed quasi-solid-state cell technology at the Faraday Institution Conference 2026 in Nottingham, placing its Goliath programme within a major energy storage innovation forum.

Ilika Plc capital raise supports Stereax launch and Goliath progress, says Cavendish

Ilika’s latest Cavendish note highlights fresh funding to support Stereax commercialisation and Goliath development across medical, defence and e-bike markets.

Defence battery demand highlights a practical growth opportunity

Defence applications are increasing the need for safer, lighter and more reliable battery technology.

Ilika raises £4.56m in oversubscribed placing and subscription

Ilika has conditionally raised approximately £4.56 million through an oversubscribed placing and subscription, with proceeds to support the commercialisation of its Stereax and Goliath solid-state battery technologies.

Search